HSIC vs JCAP · P/E 24, rev $12.67B vs rev $150.8M
Henry Schein Inc (HSIC) versus Jefferson Capital, Inc (JCAP) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Jefferson Capital, Inc (JCAP) is a credit services company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported JCAP revenue for 2025-09-30 was $150.8M. Net income was $150.2M. Revenue was down 1.2% from 2025-06-30 to 2025-09-30. JCAP currently screens at market cap $0.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. JCAP currently screens at market cap $0.
Not investment advice. Open the HSIC and JCAP stock pages for the full models.
Not investment advice.